A phase 1 multiple ascending dose (MAD) study of INCB054707, a JAK1 inhibitor, in healthy participants

The requested reference [e309adb24a666bf68b21ef498fd949ef65fee159] no longer exists in our database. It has been replaced by the current reference: [28fbdc530347fcd34b628651d6327d3fe3c5278d]

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2022
This article has no abstract
Epistemonikos ID: 1ef44764f4593d0d677a6cc893bba6d01efc4620
First added on: Apr 30, 2026